Healthcare Company Compensates for Weight Loss Treatment Discrepancy

Ranga Reddy District Consumer Commission has directed the online pharmacy 'Kolors Healthcare India Pvt Ltd' to reimburse the amount of Rs. Rewards plus compensation of Rs.

Revamped Schedule M Set to Boost Pharma Exports Pharmexcil DG

The country will take decisive action for standard improvement with its Revised Schedule M norms. This Revised Schedule M system will promote quality standards within the pharmaceutical industry, making it a growth tool for Indian exports

Gujarat's Leading Pharma Companies Sustain Growth Trajectory

The growth trend in the pharmaceutical and healthcare segment has increased in Gujarat. Also, it shows the possibility for expansion beyond the national boundaries and directly to the global market with investment

HempStreet looks to amplify the reach of Palliative Care with 'Dignity'

Delhi, April 1, HempStreet, India's first research-to-retail venture in the ayurvedic cannabis sector, is proud to announce the launch of its groundbreaking palliative care platform, Dignity.

Lupin's Migalastat Capsules Earn US FDA Tentative Approval

An FDA nod to the Abbreviated New Drug Application submitted (ANDA) by multinational pharma player Lupin Limited (Lupin) has come in. T

Laborie Medical Backs Venture iO Urology Investment

Based out of Portsmouth,,New Hampshire, a world-leading diagnostics and therapy medical technology corporation, Laborie Medical Technologies Corporation, has acquired iO Urology.

Aurobindo Pharma Opens Four Plants in Andhra Pradesh

Today, Aurobindo Pharma announced the completion of four modern 6-AAA injectables and granulation manufacturing facilities in the corporate bracket through its fully owned subsidiaries.

Possible Connection Found Between Delirium and Dementia in Recent Study

This is the report from a new retrospective study initiated in partnership with researchers from the AIHI at Macquarie University in Australia and the UQ in Queensland.

WHO Releases Updated Hepatitis B Guidelines

The World Health Organization (WHO) issued the latest advisory papers on the prevention, diagnosis, and treatment of chronic hepatitis B infection (HBV) at the APASL 2024 in Kyoto, Japan, its annual forum for studying liver diseases.

PLI Schemes Garner Rs 1.06 Trillion; Pharma Dominates

The production-linked incentive (PLI) schemes in the 14 sectors in the Philippines gathered over Rs. 1 060 billion in investments, the biggest shares of which came from pharma and solar modules.

© 2025 India Pharma Outlook. All Rights Reserved.